Key facts
- Relentless Health’s last known valuation is $20.0M (Aug 2022).
- It has raised $24.3M across 1 recorded rounds; the latest was Early Stage VC ($20.7M) in Apr 2025.
- Notable investors include StartX (US), Stony Lonesome Group.
- Relentless Health has filed 2 Form Ds with the SEC, most recently Dec 2025 ($20.7M sold to 42 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Relentless Health
Funding rounds
1 roundsAbout Relentless Health
Operator of an artificial intelligence health data platform intended to facilitate early disease prevention for effective treatment. The company's platform develops breath-based diagnostics combined with other biomarkers and helps in identifying those biomarkers for the detection of disease conditions through toxin tests, enabling medical practitioners with better care for their patients with a broad market technology for early prevention.
- Sector
- Healthcare
- HQ
- Reno, NV, United States
- Founded
- 2017
- Employees
- 27
- Website
- relentlesshealth.com/
- Ownership
- Privately Held (backing)
Relentless Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Relentless Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Relentless Health in its N-PORT filings yet. We sweep new filings monthly.